Marchex (MCHX) Tops Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts MCHX Hot Sheet
Price: $1.35 -1.46%
Revenue Growth %: +3.5%
Financial Fact:
Net income (loss) applicable to common stockholders: -5.85M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: +3.5%
Financial Fact:
Net income (loss) applicable to common stockholders: -5.85M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Marchex (NASDAQ: MCHX) reported Q4 EPS of $0.05, $0.02 better than the analyst estimate of $0.03. Revenue for the quarter came in at $33.3 million versus the consensus estimate of $31.3 million.
For earnings history and earnings-related data on Marchex (MCHX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Edwards Lifesciences (EW) Tops Q1 EPS by 2c; offers guidance
- Arca Biopharma (ABIO) Reports Q1 Loss of $0.14
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
